NPS Pharma Stock Price (NASDAQ:NPSP)

Add to My Stocks
$45.97 $0 (0%) NPSP stock closing price Feb 23, 2015 (Closing)
Prev Close* : $45.97
Market Cap:
$4.99B
Day Low: $0
52 Week Low: $22.11
Open: $0
Volume: $0
Day High: $0
52 Week High: $46.01
Dividend:
0.00

Latest Stock Market News

Latest Articles

NPS Pharma News - From Partners

Shire Completes Acquisition of NPS Pharma   by PRNews on Feb 21, 2015

NPSP Stockcharts

View NPSP PE ratio, PS ratio stocks charts and compare with peers.
NPSP Chart
Note: Compare NPS Pharma stock price history with the index and industry peers.

NPS Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
)
PB ratio (
price to book ratio
)

NPS Pharma Returns

ROE
(return on equity)

NPS Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

NPSP Industry Peers

Company Price Change (%)
Loxo Oncology (LOXO)155.751.84 (1.17%)
Fibrogen (FGEN)56.31.05 (1.83%)
Amgen (AMGN)203.20.86 (0.43%)
Abbvie (ABBV)91.021.59 (1.72%)
Cymabay (CBAY)12.090.71 (5.55%)
Abbott (ABT)68.50.09 (0.13%)
Ani Pharma (ANIP)53.320.21 (0.39%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

NPS Pharmaceuticals, Inc. Stock News - Partner Headlines

NPS Pharma Financial Statements

income statement20142013201220112010
Net Sales or Revenues224.06M155.59M130.64M101.64M89.41M
Net Income-8.7M-13.5M-18.73M-36.26M-31.44M
Total Operating Expense204.35M153.49M131.75M98.05M79.76M
View NPS Pharma income statement
balance sheet20142013201220112010
Total Assets289.61M292.22M151.1M213.98M228.9M
Total Liabilities155.79M187.33M205.75M260.09M384.18M
Shareholders Equity133.82M104.89M-54.64M-46.11M-155.27M
View NPS Pharma balance sheet
cash flow statement20142013201220112010
Net Increase (Decrease) in Assets Liabilities3.48M2.4M-14.13M12.37M-10.23M
Net Cash from (used by) Operating Activities-16.71M-24.31M-60.99M-56.65M-17.73M
Increase (Decrease) in Prop Plant And Equipment-3.09M-1.14M-1.18M-3.4M-0.86M
View NPS Pharma cash flow statement

NPS Pharma Stock Message Board

As of last trading day, NPS Pharma stock price was $45.97. Looking at NPS Pharma market capitalization, which currently stands at $4.99B, we can say that NPSP stock is a Mid Cap stock. A value investor must look at the fundamentals of a stock, and perform NPS Pharma valuation, even though in the short-term, sentiment and current breaking news might affect NPS Pharma stock price.

For recognizing and analyzing the real performance of NPS Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in NPS Pharma stock quote data shows the number of shares traded. For Ex: 0 NPS Pharma shares were traded as of last trading day, as seen from NPS Pharma stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. NPS Pharma stock dividend was 0.00 during the last quarter. NPS Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.